September 22, 2021

FRONTEO Holds Online Seminar with
US Law Firm Covington & Burling

AI and Technology Assisted Review: Best Practices & Cutting-Edge Issues in Litigations and Investigations
September 9, 2021

FRONTEO Holds Online Seminar with
US Law Firm Sidley Austin

U.S. Anti-Money Laundering Developments Affecting Cross-Border Investigations & Technology
August 4, 2021

FRONTEO’s AI review tool “KIBIT Automator” is used for legal investigation and litigation cases in an US asset management company

NEW YORK, August 4, 2021 – FRONTEO (TSE: 2158) announced that our AI review tool "KIBIT Automator" was used for an investigative case of unauthorized access and removal of confidential information in the United States.
July 28, 2021

FRONTEO Korea built AI review tool “KIBIT Automator” on NAVER cloud

By building KIBIT Automator on a cloud environment, we will create a highly reliable service platform that meets a large amount of data processing demand, improve data analysis efficiency, and reduce man-hours and costs.
April 30, 2021

FRONTEO announces next-generation eDiscovery platform

Expanded the functions of the AI review tool “KIBIT Automator” which is a key to FRONTEO’s portfolio transformation, enabling one-stop handling of eDiscovery process from pre-processing to document review.
May 6, 2020

FRONTEO Has Identified 450 Candidate Compounds In Its Research On The Novel Coronavirus (COVID-19)

April 30, 2020

FRONTEO has Constructed a Pathway Map of the Coronavirus Infection (COVID-19) to be Published for Use in Therapeutic Drug Selection and Review

April 17, 2020

FRONTEO Commences Drug Repositioning Research on Novel Coronavirus (COVID-19) Using Best-In-Class AI

April 15, 2020

FRONTEO and Kyowa Pharmaceutical Form Partnership to Diagnose Dementia Using Artificial Intelligence

April 15, 2020

FRONTEO Partners with Takeda Pharmaceutical for Drug Discovery and Development